◄ back to all posts
Financial data and stock pages provided by
Fintel.io
#WhatYouMissed On RIA This Week: 10-23-20
Oct 23, 2020
◄ back to all posts
JNJ: Johnson & Johnson Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 361,158.16 |
| Enterprise Value ($M) | 390,563.10 |
| Book Value ($M) | 64,473.00 |
| Book Value / Share | 24.49 |
| Price / Book | 5.85 |
| NCAV ($M) | -48,642.00 |
| NCAV / Share | -18.48 |
| Price / NCAV | -7.75 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.18 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.24 |
| Current Ratio | 1.48 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 57,578.00 |
| Assets | 170,693.00 |
| Liabilities | 106,220.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | n/a |
| Net Income | 15,119.00 |
| Earnings Per Share Diluted | 5.63 |
| Earnings Per Share Basic | 5.72 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 23,416.00 |
| Cash from Investing | -6,194.00 |
| Cash from Financing | -6,194.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 5.77 | 0.10 | |
| 13G/A | Vanguard Group Inc | 8.67 | 3.15 | |
| 13G/A | BlackRock Inc. | 7.30 | 5.06 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K 2019 | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 715,056 | 7,205,400 | 9.92 | |
| 673,922 | 8,426,000 | 8.00 | |
| 423,049 | 4,890,000 | 8.65 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| GSK – GlaxoSmithKline plc | HEXO – HEXO Corp. |
| HSP – Hospira | LCI – Lannett Co., Inc. |
| LLY – Eli Lilly & Co. |
Financial data and stock pages provided by
Fintel.io
2018/07/06
Also Read
